Challenges in quantifying marijuana use.
作者信息
Gray Kevin M, Watson Noreen L, Christie Douglas K
出版信息
Am J Addict. 2009 Mar-Apr;18(2):178-9. doi: 10.1080/10550490902772579.
Abstract
摘要
相似文献
1
Challenges in quantifying marijuana use.
Am J Addict. 2009 Mar-Apr;18(2):178-9. doi: 10.1080/10550490902772579.
2
[Marijuana Abuse].
Rev Assoc Med Bras (1992). 2005 Sep-Oct;51(5):247-9. doi: 10.1590/s0104-42302005000500008. Epub 2005 Oct 31.
3
Practical challenges to positive drug tests for marijuana.
Clin Chem. 2003 Jul;49(7):1037-8. doi: 10.1373/49.7.1037.
4
Sustiva may cause false positive on marijuana test.
WORLD. 1999 Apr(No 96):7.
5
Usefulness of sweat testing for the detection of cannabis smoke.
Clin Chem. 2004 Nov;50(11):1961-2. doi: 10.1373/clinchem.2004.040758.
6
Drug testing, drug treatment, and marijuana use: a fairness perspective.
J Appl Psychol. 2002 Dec;87(6):1159-66. doi: 10.1037/0021-9010.87.6.1159.
7
Psychometric properties of the Cannabis Abuse Screening Test (CAST) in a French sample of adolescents.
Drug Alcohol Depend. 2011 Jan 15;113(2-3):229-35. doi: 10.1016/j.drugalcdep.2010.08.011.
8
Substance use in pregnancy at the Mt. Hope Women's Hospital in Trinidad.
J Trop Pediatr. 2012 Aug;58(4):328-9. doi: 10.1093/tropej/fmr079. Epub 2011 Sep 22.
9
Letter to the editor: Critique of Bahorik et al. (2013)--'Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors'.
Psychol Med. 2014 Feb;44(3):668-70. doi: 10.1017/S0033291713002511. Epub 2013 Oct 28.
10
Letter to the editor: Critique of Bahorik et al. (2013)--'Underreporting of drug use among individuals with schizophrenia: prevalence and predictors'--a reply.
Psychol Med. 2014 Feb;44(3):670-1. doi: 10.1017/s0033291713002560.
引用本文的文献
1
Beyond Frequency and Quantity of Cannabis Consumption Among College Students: Context of Using Cannabis Relates to Cannabis-Related Outcomes.
Cannabis. 2025 Feb 1;8(1):65-80. doi: 10.26828/cannabis/2024/000225. eCollection 2025.
2
Exploring survey methods for measuring consumption quantities of cannabis flower and concentrate products.
Am J Drug Alcohol Abuse. 2023 Nov 2;49(6):733-745. doi: 10.1080/00952990.2023.2246635. Epub 2023 Dec 11.
3
Evaluating cannabis exposure in survey items: Insights, strategies, and remaining challenges identified from cognitive interviewing.
Drug Alcohol Depend Rep. 2023 Apr 19;7:100161. doi: 10.1016/j.dadr.2023.100161. eCollection 2023 Jun.
4
Maturing out of alcohol and cannabis co-use: A test of patterns and personality predictors.
Alcohol Clin Exp Res. 2022 Aug;46(8):1603-1615. doi: 10.1111/acer.14898. Epub 2022 Aug 22.
5
The Anticipated Effects of Cannabis Scale (AECS): Initial development and validation of an affect- and valence-based expectancy measure.
Psychol Assess. 2021 Feb;33(2):180-194. doi: 10.1037/pas0000881. Epub 2020 Nov 5.
6
Measuring Within-Individual Cannabis Reduction in Clinical Trials: A Review of the Methodological Challenges.
Curr Addict Rep. 2019 Dec;6(4):429-436. doi: 10.1007/s40429-019-00290-y. Epub 2019 Nov 19.
7
Modes of cannabis use: A secondary analysis of an intensive longitudinal natural history study.
Addict Behav. 2019 Nov;98:106033. doi: 10.1016/j.addbeh.2019.106033. Epub 2019 Jun 24.
8
Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder.
Drug Alcohol Depend. 2019 Jan 1;194:500-517. doi: 10.1016/j.drugalcdep.2018.10.020. Epub 2018 Nov 15.
9
Investigating the Relationships Between Alcohol Consumption, Cannabis Use, and Circulating Cytokines: A Preliminary Analysis.
Alcohol Clin Exp Res. 2018 Mar;42(3):531-539. doi: 10.1111/acer.13592. Epub 2018 Feb 2.
10
Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial.
Drug Alcohol Depend. 2018 Jan 1;182:1-7. doi: 10.1016/j.drugalcdep.2017.09.035. Epub 2017 Nov 2.
本文引用的文献
1
Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology.
J Forensic Sci. 2008 Jan;53(1):90-4. doi: 10.1111/j.1556-4029.2007.00603.x.
2
Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops.
Addict Biol. 2005 Jun;10(2):171-80. doi: 10.1080/13556210500123217.
3
Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980-1997.
J Forensic Sci. 2000 Jan;45(1):24-30.
4
Marijuana smoking: effects of varying puff volume and breathhold duration.
J Pharmacol Exp Ther. 1995 Feb;272(2):560-9.
5
Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations.
Br J Addict. 1988 Apr;83(4):393-402. doi: 10.1111/j.1360-0443.1988.tb00485.x.
6
Breathhold duration and response to marijuana smoke.
Pharmacol Biochem Behav. 1989 Jun;33(2):481-4. doi: 10.1016/0091-3057(89)90534-0.
7
Response to marijuana as a function of potency and breathhold duration.
Psychopharmacology (Berl). 1991;103(2):223-6. doi: 10.1007/BF02244207.
8
Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs.
J Pharmacol Exp Ther. 1992 Apr;261(1):114-22.
Zotero 插件